Information:
Fel:
ID
20211
Beskrivning
This study is a prospective, interventional, open-label, multi-center early access program for the use of Ra-223 Cl2 in HRPC/CRPC (Hormone refractory prostate cancer / Castrate resistant prostate cancer) patients diagnosed with bone metastasis and to collect additional short and long term safety data on the product. NCT01618370
Nyckelord
Versioner (1)
- 2017-02-13 2017-02-13 -
Uppladdad den
13 februari 2017
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 3.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Radium-223 Dichloride (Alpharadin) DRKS00006460 NCT01618370 in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases (Prior Therapy)
Radium 223 Dichloride (Alpharadin) - Prior Anti-Cancer Therapy
- StudyEvent: ODM
Similar models
Radium 223 Dichloride (Alpharadin) - Prior Anti-Cancer Therapy
- StudyEvent: ODM
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Prior systemic anti-cancer therapy
Item
Has the subject received any prior systemic anti-cancer therapy?
boolean
C2346834 (UMLS CUI [1,1])
C1514463 (UMLS CUI [1,2])
C1514463 (UMLS CUI [1,2])
Regimen number
Item
Regimen number
text
C0040808 (UMLS CUI [1,1])
C0237753 (UMLS CUI [1,2])
C0237753 (UMLS CUI [1,2])
Intent
Item
Intent
text
C1283828 (UMLS CUI [1,1])
C2346834 (UMLS CUI [1,2])
C2346834 (UMLS CUI [1,2])
Type of treatment
Item
Type
text
C0087111 (UMLS CUI [1])
Drug name
Item
Drug name (Trade Name preferred)
text
C0013227 (UMLS CUI [1])
Start Date
Item
Start Date
date
C0808070 (UMLS CUI [1])
Stop Date
Item
Stop Date
date
C0806020 (UMLS CUI [1])